Loss of rnf40 decreases nf-κb activity in colorectal cancer cells and reduces colitis burden in mice

Robyn Laura Kosinsky, Robert Lorenz Chua, Martin Qui, Dominik Saul, Dawid Mehlich, Philipp Ströbel, Hans Ulrich Schildhaus, Florian Wegwitz, William Alvis Faubion, Steven Johnsen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background and Aims: Inflammatory bowel diseases are linked to an increased risk of developing colorectal cancer [CRC]. Previous studies suggested that the H2B ubiquitin ligase RING finger protein-20 [RNF20] inhibited inflammatory signaling mediated by the nuclear factor kappa-lightchain- enhancer of activated B cells [NF-κB]. However, the role of RNF40, the obligate heterodimeric partner of RNF20, in the context of inflammation and CRC has not been addressed. Here, we examined the effect of RNF40 loss on CRC cells in vitro and on inflammation and inflammatory signaling in vitro and in vivo. Methods: We evaluated H2Bub1 levels in human and murine colorectal tumors by immunohistochemistry. Moreover, we correlated H2Bub1 and RNF40 levels in vivo and assessed the consequences of RNF40 depletion on cellular phenotype and gene expression in CRC cells in vitro. Finally, we examined the effect of a colon-specific loss of Rnf40 in a murine model of colitis, and assessed both local and systemic inflammation-associated consequences. Results: In vitro studies revealed that the tumorigenic phenotype of CRC cells decreased after RNF40 depletion and displayed gene expression changes related to chromosome segregation and DNA replication, as well as decreased induction of several NF-κB-associated cytokines. This effect was associated with decreased nuclear localization of NF-κB following tumor necrosis factor alpha treatment. Consistently, the colon-specific loss of Rnf40 exerted a protective local, as well as systemic, effect following acute colitis. Conclusions: Our findings suggest that RNF40 plays a central role in the maintenance of tumorigenic features and inflammatory signaling by promoting nuclear NF-κB activity.

Original languageEnglish (US)
Pages (from-to)362-373
Number of pages12
JournalJournal of Crohn's and Colitis
Volume13
Issue number3
DOIs
StatePublished - Mar 26 2019

Fingerprint

Colitis
Colorectal Neoplasms
Inflammation
Colon
Phenotype
Gene Expression
Chromosome Segregation
Ligases
Ubiquitin
DNA Replication
Inflammatory Bowel Diseases
Proteins
B-Lymphocytes
Tumor Necrosis Factor-alpha
Immunohistochemistry
Maintenance
Cytokines
In Vitro Techniques

Keywords

  • H2bub1
  • Nf-?b
  • Rnf40

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Loss of rnf40 decreases nf-κb activity in colorectal cancer cells and reduces colitis burden in mice. / Kosinsky, Robyn Laura; Chua, Robert Lorenz; Qui, Martin; Saul, Dominik; Mehlich, Dawid; Ströbel, Philipp; Schildhaus, Hans Ulrich; Wegwitz, Florian; Faubion, William Alvis; Johnsen, Steven.

In: Journal of Crohn's and Colitis, Vol. 13, No. 3, 26.03.2019, p. 362-373.

Research output: Contribution to journalArticle

Kosinsky, RL, Chua, RL, Qui, M, Saul, D, Mehlich, D, Ströbel, P, Schildhaus, HU, Wegwitz, F, Faubion, WA & Johnsen, S 2019, 'Loss of rnf40 decreases nf-κb activity in colorectal cancer cells and reduces colitis burden in mice', Journal of Crohn's and Colitis, vol. 13, no. 3, pp. 362-373. https://doi.org/10.1093/ecco-jcc/jjy165
Kosinsky, Robyn Laura ; Chua, Robert Lorenz ; Qui, Martin ; Saul, Dominik ; Mehlich, Dawid ; Ströbel, Philipp ; Schildhaus, Hans Ulrich ; Wegwitz, Florian ; Faubion, William Alvis ; Johnsen, Steven. / Loss of rnf40 decreases nf-κb activity in colorectal cancer cells and reduces colitis burden in mice. In: Journal of Crohn's and Colitis. 2019 ; Vol. 13, No. 3. pp. 362-373.
@article{4b6e706cc47b4bce861a46e0903601de,
title = "Loss of rnf40 decreases nf-κb activity in colorectal cancer cells and reduces colitis burden in mice",
abstract = "Background and Aims: Inflammatory bowel diseases are linked to an increased risk of developing colorectal cancer [CRC]. Previous studies suggested that the H2B ubiquitin ligase RING finger protein-20 [RNF20] inhibited inflammatory signaling mediated by the nuclear factor kappa-lightchain- enhancer of activated B cells [NF-κB]. However, the role of RNF40, the obligate heterodimeric partner of RNF20, in the context of inflammation and CRC has not been addressed. Here, we examined the effect of RNF40 loss on CRC cells in vitro and on inflammation and inflammatory signaling in vitro and in vivo. Methods: We evaluated H2Bub1 levels in human and murine colorectal tumors by immunohistochemistry. Moreover, we correlated H2Bub1 and RNF40 levels in vivo and assessed the consequences of RNF40 depletion on cellular phenotype and gene expression in CRC cells in vitro. Finally, we examined the effect of a colon-specific loss of Rnf40 in a murine model of colitis, and assessed both local and systemic inflammation-associated consequences. Results: In vitro studies revealed that the tumorigenic phenotype of CRC cells decreased after RNF40 depletion and displayed gene expression changes related to chromosome segregation and DNA replication, as well as decreased induction of several NF-κB-associated cytokines. This effect was associated with decreased nuclear localization of NF-κB following tumor necrosis factor alpha treatment. Consistently, the colon-specific loss of Rnf40 exerted a protective local, as well as systemic, effect following acute colitis. Conclusions: Our findings suggest that RNF40 plays a central role in the maintenance of tumorigenic features and inflammatory signaling by promoting nuclear NF-κB activity.",
keywords = "H2bub1, Nf-?b, Rnf40",
author = "Kosinsky, {Robyn Laura} and Chua, {Robert Lorenz} and Martin Qui and Dominik Saul and Dawid Mehlich and Philipp Str{\"o}bel and Schildhaus, {Hans Ulrich} and Florian Wegwitz and Faubion, {William Alvis} and Steven Johnsen",
year = "2019",
month = "3",
day = "26",
doi = "10.1093/ecco-jcc/jjy165",
language = "English (US)",
volume = "13",
pages = "362--373",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Loss of rnf40 decreases nf-κb activity in colorectal cancer cells and reduces colitis burden in mice

AU - Kosinsky, Robyn Laura

AU - Chua, Robert Lorenz

AU - Qui, Martin

AU - Saul, Dominik

AU - Mehlich, Dawid

AU - Ströbel, Philipp

AU - Schildhaus, Hans Ulrich

AU - Wegwitz, Florian

AU - Faubion, William Alvis

AU - Johnsen, Steven

PY - 2019/3/26

Y1 - 2019/3/26

N2 - Background and Aims: Inflammatory bowel diseases are linked to an increased risk of developing colorectal cancer [CRC]. Previous studies suggested that the H2B ubiquitin ligase RING finger protein-20 [RNF20] inhibited inflammatory signaling mediated by the nuclear factor kappa-lightchain- enhancer of activated B cells [NF-κB]. However, the role of RNF40, the obligate heterodimeric partner of RNF20, in the context of inflammation and CRC has not been addressed. Here, we examined the effect of RNF40 loss on CRC cells in vitro and on inflammation and inflammatory signaling in vitro and in vivo. Methods: We evaluated H2Bub1 levels in human and murine colorectal tumors by immunohistochemistry. Moreover, we correlated H2Bub1 and RNF40 levels in vivo and assessed the consequences of RNF40 depletion on cellular phenotype and gene expression in CRC cells in vitro. Finally, we examined the effect of a colon-specific loss of Rnf40 in a murine model of colitis, and assessed both local and systemic inflammation-associated consequences. Results: In vitro studies revealed that the tumorigenic phenotype of CRC cells decreased after RNF40 depletion and displayed gene expression changes related to chromosome segregation and DNA replication, as well as decreased induction of several NF-κB-associated cytokines. This effect was associated with decreased nuclear localization of NF-κB following tumor necrosis factor alpha treatment. Consistently, the colon-specific loss of Rnf40 exerted a protective local, as well as systemic, effect following acute colitis. Conclusions: Our findings suggest that RNF40 plays a central role in the maintenance of tumorigenic features and inflammatory signaling by promoting nuclear NF-κB activity.

AB - Background and Aims: Inflammatory bowel diseases are linked to an increased risk of developing colorectal cancer [CRC]. Previous studies suggested that the H2B ubiquitin ligase RING finger protein-20 [RNF20] inhibited inflammatory signaling mediated by the nuclear factor kappa-lightchain- enhancer of activated B cells [NF-κB]. However, the role of RNF40, the obligate heterodimeric partner of RNF20, in the context of inflammation and CRC has not been addressed. Here, we examined the effect of RNF40 loss on CRC cells in vitro and on inflammation and inflammatory signaling in vitro and in vivo. Methods: We evaluated H2Bub1 levels in human and murine colorectal tumors by immunohistochemistry. Moreover, we correlated H2Bub1 and RNF40 levels in vivo and assessed the consequences of RNF40 depletion on cellular phenotype and gene expression in CRC cells in vitro. Finally, we examined the effect of a colon-specific loss of Rnf40 in a murine model of colitis, and assessed both local and systemic inflammation-associated consequences. Results: In vitro studies revealed that the tumorigenic phenotype of CRC cells decreased after RNF40 depletion and displayed gene expression changes related to chromosome segregation and DNA replication, as well as decreased induction of several NF-κB-associated cytokines. This effect was associated with decreased nuclear localization of NF-κB following tumor necrosis factor alpha treatment. Consistently, the colon-specific loss of Rnf40 exerted a protective local, as well as systemic, effect following acute colitis. Conclusions: Our findings suggest that RNF40 plays a central role in the maintenance of tumorigenic features and inflammatory signaling by promoting nuclear NF-κB activity.

KW - H2bub1

KW - Nf-?b

KW - Rnf40

UR - http://www.scopus.com/inward/record.url?scp=85060878832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060878832&partnerID=8YFLogxK

U2 - 10.1093/ecco-jcc/jjy165

DO - 10.1093/ecco-jcc/jjy165

M3 - Article

C2 - 30321325

AN - SCOPUS:85060878832

VL - 13

SP - 362

EP - 373

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

IS - 3

ER -